- Home
- ABEO vs EH Comparison
ABEO vs EH Comparison
Compare ABEO & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | EH |
|---|---|---|
| Founded | 1974 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.5M | 464.9M |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ABEO | EH |
|---|---|---|
| Price | $6.83 | $5.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $20.00 | ★ $22.47 |
| AVG Volume (30 Days) | ★ 1.2M | 845.2K |
| Earning Date | 05-13-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | $1,024.31 | $33.23 |
| Revenue Next Year | $145.42 | $73.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $4.00 | $4.89 |
| 52 Week High | $7.54 | $20.20 |
Technical Indicators
Market Signals| Indicator | ABEO | EH |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 46.69 |
| Support Level | N/A | $4.89 |
| Resistance Level | N/A | $6.98 |
| Average True Range (ATR) | 0.00 | 0.27 |
| MACD | 0.00 | 0.14 |
| Stochastic Oscillator | 0.00 | 88.08 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company focused on autonomous aerial vehicle technology and solutions. The company provides unmanned aerial vehicle (UAV) systems and solutions for air mobility, including passenger transportation and logistics, as well as smart city management and aerial media solutions. Its EH216-S passenger-carrying pilotless eVTOL aircraft has obtained a production certificate and standard airworthiness certificate from the Civil Aviation Administration of China (CAAC).